Pages that link to "Q58454772"
Jump to navigation
Jump to search
The following pages link to Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma (Q58454772):
Displaying 50 items.
- A network-based method to evaluate quality of reproducibility of differential expression in cancer genomics studies (Q28602622) (← links)
- In vivo selection for metastasis promoting genes in the mouse (Q33281597) (← links)
- C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. (Q34124421) (← links)
- Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung (Q34173005) (← links)
- Prognostic factors in stage I/II non-small cell lung cancer (Q34384392) (← links)
- Molecular staging of lung and esophageal cancer (Q34951790) (← links)
- Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies (Q35179415) (← links)
- Role of HGF/MET axis in resistance of lung cancer to contemporary management (Q35200337) (← links)
- The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature (Q35216052) (← links)
- Expression of ribosome-binding protein 1 correlates with shorter survival in Her-2 positive breast cancer (Q35754274) (← links)
- Novel targeted agents in the treatment of lung cancer (Q35790783) (← links)
- Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers (Q36107033) (← links)
- Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissue (Q36116240) (← links)
- Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections (Q36135626) (← links)
- Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma (Q36335248) (← links)
- Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression (Q36431673) (← links)
- Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer (Q36623274) (← links)
- Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer (Q36641208) (← links)
- Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer (Q36642239) (← links)
- Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas (Q36644476) (← links)
- ErbBs in lung cancer (Q37249978) (← links)
- NOV-002, A Glutathione Disulfide Mimetic, Suppresses Tumor Cell Invasion and Metastasis (Q37414455) (← links)
- Selection of a novel DNA thioaptamer against HER2 structure (Q38298656) (← links)
- A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma (Q38611422) (← links)
- Increasing of HER2 membranar density in human glioblastoma U251MG cell line established in a new nude mice model (Q40366512) (← links)
- Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer (Q40422302) (← links)
- Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549. (Q40462593) (← links)
- Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer. (Q40555102) (← links)
- Clinical utility of cytologic typing of lung tumors (Q40632046) (← links)
- Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study. (Q40687098) (← links)
- A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes (Q40864858) (← links)
- ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells (Q40925406) (← links)
- New prognostic factors in resectable non-small cell lung cancer (Q41023437) (← links)
- Recurrence Risk-Scoring Model for Stage I Adenocarcinoma of the Lung (Q41201087) (← links)
- Prognostic markers in resectable non-small cell lung cancer (Q41519933) (← links)
- Non-small cell lung cancer: clinical value of new biological predictors (Q41523353) (← links)
- Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody. (Q41524948) (← links)
- The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands (Q41738022) (← links)
- c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis. (Q43576637) (← links)
- Herceptest: HER2 expression and gene amplification in non-small cell lung cancer (Q43576640) (← links)
- Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancer. (Q46818912) (← links)
- Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung (Q47418103) (← links)
- Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins (Q47771319) (← links)
- Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade glioma (Q48135134) (← links)
- Progress in understanding the molecular pathogenesis of human lung cancer. (Q53431081) (← links)
- Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells. (Q55001941) (← links)
- MicroRNA-133a Inhibits Proliferation of Gastric Cancer Cells by Downregulating ERBB2 Expression. (Q55005278) (← links)
- The close relationship between growth factors and the nucleolar organizer regions in adenocarcinoma of the lung (Q58454753) (← links)
- Aptamer-Modified Magnetic Nanosensitizer for In Vivo MR Imaging of HER2-Expressing Cancer (Q58726892) (← links)
- bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma (Q59219555) (← links)